Early Value Assessment in Gene Therapy Clinical Trial Design
A global biotechnology company engineering precision genetic medicine for rare diseases was in need of expertise in early assessment of proposed clinical trial designs and their potential payer coverage. They engaged with Certara’s Cell & Gene Therapy practice because of its proven experience in tailoring commercialization support to the needs of gene therapy drug development.
The team was blown away by how quickly we were able to pull this off and the insights we received from you. THANK YOU for making our lives easier and exceeding the expectations of the team!